Strategic Partnerships my mhealth's collaborations with prominent partners such as NHS organizations, AstraZeneca, and academic institutions indicate a strong network within healthcare and pharmaceutical sectors, presenting opportunities for expanding digital therapeutics solutions across public health systems and global pharma clients.

Digital Therapeutics Focus Specializing in digital therapeutics for chronic conditions like COPD, heart disease, asthma, and diabetes, my mhealth is well-positioned to offer innovative, scalable health management platforms that can be integrated into hospital and insurer offerings, appealing to organizations seeking to enhance patient engagement and reduce healthcare costs.

Market Potential With a revenue range between $1M and $10M and a modest funding of $624K, my mhealth operates within a sizable yet targeted market niche, suggesting growth opportunities through increased fundraise, strategic partnerships, or entry into broader health sectors such as oncology, exemplified by their recent collaboration with AstraZeneca.

Technology Stack Utilizing modern web and analytics tools like Google Analytics, Amazon SES, and Duda, my mhealth demonstrates a strong digital infrastructure capable of supporting personalized and scalable telehealth solutions—valuable for clients seeking reliable and data-driven health platforms.

Expansion Opportunities Given their current focus on partnerships and digital health solutions, there is significant potential to target large insurers, health systems, and pharma companies interested in digital therapeutics for chronic disease management and oncology, positioning my mhealth as a key vendor for innovative health technology implementations.